Melitide® contains liraglutide, an analog of human glucagon-like peptide-1 (GLP-1) and acts as a GLP-1 receptor agonist. Melitide® multidose pen is an injectable prescription medicine.Along with diet and exercise to lower blood sugar (glucose) in adults and children who are 10 years of age and older with type 2 diabetes mellitus
To reduce the risk of major cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes mellitus with known heart disease.
